This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (578) Substance Abuse (426) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (158)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/43122, first published .
A Prescription Digital Therapeutic to Support Unsupervised Buprenorphine Initiation for Patients With Opioid Use Disorder: Protocol for a Proof-of-Concept Study

A Prescription Digital Therapeutic to Support Unsupervised Buprenorphine Initiation for Patients With Opioid Use Disorder: Protocol for a Proof-of-Concept Study

A Prescription Digital Therapeutic to Support Unsupervised Buprenorphine Initiation for Patients With Opioid Use Disorder: Protocol for a Proof-of-Concept Study

Authors of this article:

Hilary Luderer1 Author Orcid Image ;   Nicole Enman1 Author Orcid Image ;   Robert Gerwien1 Author Orcid Image ;   Stephen Braun1 Author Orcid Image ;   Samantha McStocker1 Author Orcid Image ;   Xiaorui Xiong1 Author Orcid Image ;   Carrington Koebele2 Author Orcid Image ;   Christopher Cannon2 Author Orcid Image ;   Joseph Glass3 Author Orcid Image ;   Yuri Maricich1 Author Orcid Image
Article Authors Cited by (2) Tweetations (3) Metrics

Hilary Luderer   1 , PhD ;   Nicole Enman   1 , PhD ;   Robert Gerwien   1 , PhD ;   Stephen Braun   1 , BA ;   Samantha McStocker   1 , BSc ;   Xiaorui Xiong   1 , PhD ;   Carrington Koebele   2 , MD ;   Christopher Cannon   2 , MPH ;   Joseph Glass   3 , PhD ;   Yuri Maricich   1 , MD, MPH

1 Pear Therapeutics (US), Inc, Boston, MA, United States

2 Whitman-Walker Institute, Washington, DC, United States

3 Kaiser Permanente Washington Health Research Institute, Seattle, WA, United States

Corresponding Author: